Ergomed PLC (AIM:ERGO, ETR:2EM) has de-listed from AIM following the completion of a £703 million takeover by private equity group Permira but expects its growth to continue.
Miroslav Reljanović, Ergomed’s executive chairman, said: “With a strong commitment to service quality and customer service, Ergomed has grown significantly to become a global, geographically diversified player in the CRO and PV sectors.
“Permira is a highly experienced healthcare investor with a track record of building successful global businesses, which will support us to build on the foundations we have created.
“Permira brings operational expertise, a global network, capital and, equally importantly, a like-minded approach to how to accelerate our growth.
“We believe the acquisition will significantly increase our ability to invest in our geographical expansion, commercial infrastructure, and technology, and to execute strategic M&A in both the CRO and PV businesses.”